IPSC vs PSA · rev $6.6M vs rev $4.82B
Century Therapeutics Inc (IPSC) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
IPSC currently screens at market cap $47.8M. PSA currently screens at market cap $0.
Not investment advice. Open the IPSC and PSA stock pages for the full models.
Not investment advice.